Chapter 1 - Urinary bladder
Published online by Cambridge University Press: 05 July 2016
- Type
- Chapter
- Information
- Pathology of the Urinary BladderAn Algorithmic Approach, pp. 1 - 163Publisher: Cambridge University PressPrint publication year: 2000
References
Further reading
Alonso, A, Ikinger, U, Kartenbeck, J. Staining patterns of keratins in the human urinary tract. Histol Histopathol 2009;24(11):1425–37.Google ScholarPubMed
Council, L, Hameed, O. Differential expression of immunohistochemical markers in bladder smooth muscle and myofibroblasts, and the potential utility of desmin, smoothelin, and vimentin in staging of bladder carcinoma. Mod Pathol 2009;22(5):639–50.CrossRefGoogle ScholarPubMed
Lopez-Beltran, A. Immunohistochemical markers in evaluation of urinary and bladder tumors. Anal Quant Cytol Histol 2007;29(2):121–2.Google ScholarPubMed
Montironi, R, Lopez-Beltran, A, Scarpelli, M, Mazzucchelli, R, Cheng, L. Morphological classification and definition of benign, preneoplastic and non-invasive neoplastic lesions of the urinary bladder. Histopathology 2008;53(6):621–33.CrossRefGoogle ScholarPubMed
Paner, GP, Shen, SS, Lapetino, S, et al. Diagnostic utility of antibody to smoothelin in the distinction of muscularis propria from muscularis mucosae of the urinary bladder: a potential ancillary tool in the pathologic staging of invasive urothelial carcinoma. Am J Surg Pathol 2009;33(1):91–8.CrossRefGoogle ScholarPubMed
Further reading
Almeida, M, Canas-Marques, R, Lopez-Beltran, A, et al. Small cell carcinoma of the bladder associated with schistosomiasis: a case report. Anal Quant Cytopathol Histpathol 2014;36(6):339–44.Google ScholarPubMed
Cheng, L, Bostwick, DG. Overdiagnosis of bladder carcinoma. Anal Quant Cytol Histol 2008;30(5):261–4.Google ScholarPubMed
Cheng, L, Cheville, JC, Sebo, TJ, et al. Atypical nephrogenic metaplasia of the urinary tract: a precursor lesion? Cancer 2000;88:853–61.3.0.CO;2-H>CrossRefGoogle ScholarPubMed
Manimaran, D, Karthikeyan, TM, Screenivasulu, M, Mrinalini, VR, Gopinath, V. Eosinophilic cystitis mimicking bladder tumour – a rare case report. J Clin Diagn Res 2013;7(10):2282–3.Google Scholar
Fleischmann, A, Thalmann, G, Perren, A, Seiler, R. Tumor regression grade of urothelial bladder cancer after neoadjuvant chemotherapy: a novel and successful strategy to predict survival. Am J Surg Pathol 2014;38(3):325–32.CrossRefGoogle ScholarPubMed
Fuller, TW, Dangle, P, Reese, JN, et al. Inflammatory myofibroblastic tumor of the bladder masquerading as eosinophilic cystitis: case report and review of the literature. Urology 2015;85(4):921–3.CrossRefGoogle ScholarPubMed
Gupta, A, Wang, HL, Policarpio-Nicolas, ML, et al. Expression of alpha-methylacyl-coenzyme A racemase in nephrogenic adenoma. Am J Surg Pathol 2004;28:1224–9.CrossRefGoogle ScholarPubMed
Halat, S, Eble, JN, Grignon, DJ, et al. Ectopic prostatic tissue: histogenesis and histopathological characteristics. Histopathology 2011;58(5):750–8.CrossRefGoogle ScholarPubMed
Hameed, O, Humphrey, PA. Pseudoneoplastic mimics of prostate and bladder carcinomas. Arch Pathol Lab Med 2010;134(3):427–43.CrossRefGoogle ScholarPubMed
Lane, Z, Epstein, JI. Polypoid/papillary cystitis: a series of 41 cases misdiagnosed as papillary urothelial neoplasia. Am J Surg Pathol 2008;32(5):758–64.CrossRefGoogle ScholarPubMed
López, JI, Schiavo-Lena, M, Corominas-Cishek, A, et al. Nephrogenic adenoma of the urinary tract: clinical, histological, and immunohistochemical characteristics. Virchows Arch 2013;463(6):819–25.CrossRefGoogle ScholarPubMed
Lopez-Beltran, A, Luque, RJ, Mazzucchelli, R, et al. Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer. J Clin Pathol 2002;55:641–7.CrossRefGoogle ScholarPubMed
McDaniel, AS, Chinnaiyan, AM, Siddiqui, J, McKenney, JK, Mehra, R. Immunohistochemical staining characteristics of nephrogenic adenoma using the PIN-4 cocktail (p63, AMACR, and CK903) and GATA-3. Am J Surg Pathol 2014;38(12):1664–71.CrossRefGoogle ScholarPubMed
Morton, MJ, Zhang, S, Lopez-Beltran, A, et al. Telomere shortening and chromosomal abnormalities in intestinal metaplasia of the urinary bladder. Clin Cancer Res 2007;13(20):6232–6.CrossRefGoogle ScholarPubMed
Mosholt, KS, Dahl, C, Azawi, NH. Eosinophilic cystitis: three cases, and a review over 10 years. BMJ Case Rep doi: 10.1136/bcr-2014-205708. Epub 2014, Oct 13.CrossRefGoogle Scholar
Piña-Oviedo, S, Shen, SS, Truong, LD, Ayala, AG, Ro, JY. Flat pattern of nephrogenic adenoma: previously unrecognized pattern unveiled using PAX2 and PAX8 immunohistochemistry. Mod Pathol 2013;26(6):792–8.CrossRefGoogle ScholarPubMed
Sung, MT, Lopez-Beltran, A, Eble, JN, et al. Divergent pathway of intestinal metaplasia and cystitis glandularis of the urinary bladder. Mod Pathol 2006;19:1395–401.CrossRefGoogle ScholarPubMed
Sung, MT, Zhang, S, MacLennan, GT, et al. Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin. Clin Cancer Res 2008;14(7):1947–55.CrossRefGoogle ScholarPubMed
Tamas, EF, Epstein, JI. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains. Am J Surg Pathol 2007;31(3):390–7.CrossRefGoogle ScholarPubMed
Tong, GX, Weeden, EM, Hamele-Bena, D, et al. Expression of PAX8 in nephrogenic adenoma and clear cell adenocarcinoma of the lower urinary tract: evidence of related histogenesis? Am J Surg Pathol 2008;32(9):1380–7.CrossRefGoogle ScholarPubMed
Young, RH. Tumor-like lesions of the urinary bladder. Mod Pathol 2009;22(2):S37–52.CrossRefGoogle ScholarPubMed
Yu, DC, Patel, P, Bonert, M, et al. Urinary bladder xanthoma: a multi-institutional series of 17 cases. Histopathology 2015;67(2) 255–6 doi:10.1111/his.12647. Epub 2015, Feb 19.CrossRefGoogle ScholarPubMed
Further reading
Amin, MB, Trpkov, K, Lopez-Beltran, A, et al. Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol 2014;38:e20–34.CrossRefGoogle ScholarPubMed
Aron, M, Luthringer, DJ, McKenney, JK, et al. Utility of a triple antibody cocktail intraurothelial neoplasm-3 (IUN-3-CK20/CD44s/p53) and alphamethylacyl-CoA racemase (AMACR) in the distinction of urothelial carcinoma in situ (CIS) and reactive urothelial atypia. Am J Surg Pathol 2013;37(12):1815–23.CrossRefGoogle ScholarPubMed
Chan, TY, Epstein, JI. Radiation or chemotherapy cystitis with “pseudocarcinomatous” features. Am J Surg Pathol 2004;28:909–13.CrossRefGoogle ScholarPubMed
Cheng, L, Cheville, JC, Neumann, RM, et al. Natural history of urothelial dysplasia of the bladder. Am J Surg Pathol 1999;23:443–7.CrossRefGoogle ScholarPubMed
Cheng, L, Cheville, JC, Neumann, RM, et al. Flat intraepithelial lesions of the urinary bladder. Cancer 2000;88:625–31.3.0.CO;2-A>CrossRefGoogle ScholarPubMed
Cheng, L, Davidson, DD, MacLennan, GT, et al. The origins of urothelial carcinoma. Expert Rev Anticancer Ther 2010;10(6):865–80.CrossRefGoogle ScholarPubMed
Cheng, L, Zhang, S, Davidson, DD, et al. Molecular determinants of tumor recurrence in the urinary bladder. Future Oncol 2009;5(6):843–57.CrossRefGoogle ScholarPubMed
Edgecombe, A, Nguyen, BN, Djordjevic, B, Belanger, EC, Mai, KT. Utility of cytokeratin 5/6, cytokeratin 20, and p16 in the diagnosis of reactive urothelial atypia and noninvasive component of urothelial neoplasia. Appl Immunohistochem Mol Morphol 2012;20(3):264–71.CrossRefGoogle ScholarPubMed
Emerson, RE, Cheng, L. Immunohistochemical markers in the evaluation of tumors of the urinary bladder: a review. Anal Quant Cytol Histol 2005;27:301–16.Google ScholarPubMed
Gunia, S, Kakies, C, Erbersdobler, A, Koch, S, May, M. Scoring the percentage of Ki67 positive nuclei is superior to mitotic count and the mitosis marker phosphohistone H3 (PHH3) in terms of differentiating flat lesions of the bladder mucosa. J Clin Pathol 2012;65(8):715–20.CrossRefGoogle ScholarPubMed
Gunia, S, Kakies, C, May, M, Koch, S, Erbersdobler, A. Lewis(y) antigen (blood group 8, BG8) is a useful marker in the histopathological differential diagnosis of flat urothelial lesions of the urinary bladder. J Clin Pathol 2011;64(8):672–6.CrossRefGoogle ScholarPubMed
Gunia, S, Koch, S, Hakenberg, OW, et al. Different HER2 protein expression profiles aid in the histologic differential diagnosis between urothelial carcinoma in situ (CIS) and non-CIS conditions (dysplasia and reactive atypia) of the urinary bladder mucosa. Am J Clin Pathol 2011;136(6):881–8.CrossRefGoogle ScholarPubMed
Hartmann, A, Moser, K, Kriegmair, M, et al. Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma. Am J Pathol 1999;154:721–7.CrossRefGoogle ScholarPubMed
Hartmann, A, Schlake, G, Zaak, D, et al. Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder. Cancer Res 2002;62:809–18.Google ScholarPubMed
Hodges, KB, Lopez-Beltran, A, Davidson, DD, Montironi, R, Cheng, L. Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features. Hum Pathol 2010;41(2):155–62.CrossRefGoogle ScholarPubMed
Hodges, KB, Lopez-Beltran, A, Emerson, RE, Montironi, R, Cheng, L. Clinical utility of immunohistochemistry in the diagnoses of urinary bladder neoplasia. Appl Immunohistochem Mol Morphol 2010;18(5):401–10.CrossRefGoogle ScholarPubMed
Jung, S, Wu, C, Eslami, Z, et al. The role of immunohistochemistry in the diagnosis of flat urothelial lesions: a study using CK20, CK5/6, P53, Cd138, and Her2/neu. Ann Diagn Pathol 2014;18:27–32.CrossRefGoogle ScholarPubMed
Kiemeney, L, Witjes, J, Heibroek, R, et al. Dysplasia in normal-looking urothelium increases the risk of tumour progression in primary superficial bladder cancer. Eur J Cancer 1994;30A:1621–5.Google ScholarPubMed
Lacy, S, Lopez-Beltran, A, MacLennan, GT, et al. Molecular pathogenesis of urothelial carcinoma: the clinical utility of emerging new biomarkers and future molecular classification of bladder cancer. Anal Quant Cytol Histol 2009;31(1):5–16.Google ScholarPubMed
Lopez-Beltran, A. Bladder cancer: clinical and pathological profile. Scand J Urol Nephrol Suppl 2008;218:95–109.CrossRefGoogle Scholar
Lopez-Beltran, A, Algaba, F, Berney, DM, et al. Handling and reporting of transurethral resection specimens of the bladder in Europe: a web-based survey by the European Network of Uropathology (ENUP). Histopathology 2011;58(4):579–85.CrossRefGoogle ScholarPubMed
Lopez-Beltran, A, Alvarez-Kindelan, J, Luque, RJ, et al. Loss of heterozygosity at 9q32-33 (DBC1 locus) in primary non-invasive papillary urothelial neoplasm of low malignant potential and low-grade urothelial carcinoma of the bladder and their associated normal urothelium. J Pathol 2008;215(3):263–72.CrossRefGoogle ScholarPubMed
Lopez-Beltran, A, Cheng, L, Andersson, L, et al. Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the Ancona international consultation. Virchows Arch 2002;440:3–11.CrossRefGoogle ScholarPubMed
Lopez-Beltran, A, Jimenez, RE, Montironi, R, et al. Flat urothelial carcinoma in situ of the bladder with glandular differentiation. Hum Pathol 2011;42(11):1653–9.CrossRefGoogle ScholarPubMed
Lopez-Beltran, A, Luque, RJ, Mazzuchelli, R, et al. Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer. J Clin Pathol 2002;55:641–7.CrossRefGoogle ScholarPubMed
Lopez-Beltran, A, Luque, RJ, Moreno, A, Bollito, E. The pagetoid variant of bladder urothelial carcinoma in situ: a clinicopathological study of 11 cases. Virchows Arch 2002;441:148–53.CrossRefGoogle Scholar
Lopez-Beltran, A, Marques, RC, Montironi, R, et al. Dysplasia and carcinoma in situ of the urinary bladder. Anal Quant Cytopathol Histpathol 2015;37:111–15.Google ScholarPubMed
Lopez-Beltran, A, Montironi, R, Vidal, A, et al. Urothelial dysplasia of the bladder: diagnostic features and clinical significance. Anal Quant Cytopathol Histopathol 2013;35(3):121–9.Google ScholarPubMed
Lopez-Beltran, A, Ordóñez, JL, Otero, AP, et al. Cyclin D3 gene amplification in bladder carcinoma in situ. Virchows Arch 2010;457(5):555–61.CrossRefGoogle ScholarPubMed
McKenney, JK, Desai, S, Cohen, C, et al. Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens. Am J Surg Pathol 2001;25:1074–8.CrossRefGoogle ScholarPubMed
McKenney, JK, Gomez, JA, Desai, S, et al. Morphologic expressions of urothelial carcinoma in situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion. Am J Surg Pathol 2001;25:356–62.CrossRefGoogle Scholar
Montironi, R, Cheng, L, Scarpelli, M, Mazzucchelli, R, Lopez-Beltran, A. How much do you know about benign, preneoplastic, non-invasive and invasive neoplastic lesions of the urinary bladder classified according to the 2004 WHO scheme? Diagn Pathol 2011;6:31.CrossRefGoogle Scholar
Montironi, R, Lopez-Beltran, A, Scarpelli, M, Mazzucchelli, R, Cheng, L. Morphological classification and definition of benign, preneoplastic and non-invasive neoplastic lesions of the urinary bladder. Histopathology 2008;53(6):621–33.CrossRefGoogle ScholarPubMed
Murata, S, Iseki, M, Kinjo, M, et al. Molecular and immunohistologic analyses cannot reliably solve diagnostic variation of flat intraepithelial lesions of the urinary bladder. Am J Clin Pathol 2010;134(6):862–72.CrossRefGoogle ScholarPubMed
Oliva, E, Pinheiro, NF, Heney, NM, et al. Immunohistochemistry as an adjunct in the differential diagnosis of radiation-induced atypia versus urothelial carcinoma in situ of the bladder: a study of 45 cases. Hum Pathol 2013;44:860–6.CrossRefGoogle ScholarPubMed
Oxley, JD, Cottrell, AM, Adams, S, Gillatt, D. Ketamine cystitis as a mimic of carcinoma in situ. Histopathology 2009;55:705–8.CrossRefGoogle ScholarPubMed
Shirai, T, Fukushima, S, Hirose, M, Ohshima, M, Ito, N. Epithelial lesions of the urinary bladder in 313 autopsy cases. Jpn J Cancer Res 1987;78:1073–80.Google ScholarPubMed
Tamas, EF, Epstein, JI. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains. Am J Surg Pathol 2007;31:390–7.CrossRefGoogle ScholarPubMed
Williamson, SR, Montironi, R, Lopez-Beltran, A, et al. Diagnosis, evaluation and treatment of carcinoma in situ of the urinary bladder: the state of the art. Crit Rev Oncol Hematol 2010;76(2):112–26.CrossRefGoogle ScholarPubMed
Zuk, R, Rogers, H, Martin, J, et al. Clinicopathological importance of primary dysplasia of bladder. J Clin Pathol 1988;41:1277–80.CrossRefGoogle ScholarPubMed
Further reading
Al Bashir, S, Yilmaz, A, Gotto, G, Trpkov, K. Long term outcome of primary urothelial papilloma: a single institution cohort. Pathology 2014;46:37–40.CrossRefGoogle ScholarPubMed
Cheng, CW, Chan, LW, Chan, CK, et al. Is surveillance necessary for inverted papilloma in the urinary bladder and urethra? ANZ J Surg 2005;75:213–17.CrossRefGoogle ScholarPubMed
Cheng, L, Darson, M, Cheville, JC, et al. Urothelial papilloma of the bladder: clinical and biologic implications. Cancer 1999;86:2098–101.3.0.CO;2-9>CrossRefGoogle ScholarPubMed
Cheng, L, Leibovich, BC, Cheville, JC, et al. Squamous papilloma of the urinary tract is unrelated to condyloma acuminata. Cancer 2000;88:1679–86.3.0.CO;2-K>CrossRefGoogle ScholarPubMed
Chow, N, Cairns, P, Eisenberger, CF, et al. Papillary urothelial hyperplasia is a clonal precursor to papillary transitional cell bladder cancer. Int J Cancer 2000;89:514–18.3.0.CO;2-H>CrossRefGoogle ScholarPubMed
Guo, CC, Fine, SW, Epstein, JI. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases. Am J Surg Pathol 2006;30:883–91.CrossRefGoogle ScholarPubMed
Harnden, P, Mahmood, N, Southgate, J. Expression of cytokeratin 20 redefines urothelial papillomas of the bladder. Lancet 1999;353:974–7.CrossRefGoogle ScholarPubMed
Jones, TD, Zhang, S, Lopez-Beltran, A, et al. Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in-situ hybridization, immunohistochemistry, and morphologic analysis. Am J Surg Pathol 2007;31(12):1861–7.CrossRefGoogle ScholarPubMed
Sung, MT, Eble, JN, Wang, M, et al. Inverted papilloma of the urinary bladder: a molecular genetic appraisal. Mod Pathol 2006;19:1289–94.CrossRefGoogle ScholarPubMed
Sung, MT, MacLennan, GT, Lopez-Beltran, A, et al. Natural history of urothelial inverted papilloma. Cancer 2006;107:2622–7.CrossRefGoogle ScholarPubMed
van Rhijn, BW, Montironi, R, Zwarthoff, EC, et al. Frequent FGFR3 mutations in urothelial papilloma. J Pathol 2002;198:245–51.CrossRefGoogle ScholarPubMed
Williamson, SR, Zhang, S, Lopez-Beltran, A, et al. Telomere shortening distinguishes inverted urothelial neoplasms. Histopathology 2013;62(4):595–601.CrossRefGoogle ScholarPubMed
Further reading
Algaba, F, Arce, Y, Lopez-Beltran, A, et al. Intraoperative frozen section diagnosis in urological oncology. Eur Urol 2005;47:129–36.CrossRefGoogle ScholarPubMed
Alvarez, KJ, Lopez-Beltran, A, Anglada, CF, et al. Clinico-pathologic differences between bladder neoplasm with low malignant potential and low-grade carcinoma. Actas Urol Esp 2001;25:645–50.Google Scholar
Amin, MB, Ro, JY, Lee, KM, et al. Lymphoepithelioma-like carcinoma of the urinary bladder. Am J Surg Pathol 1994;18:466–73.CrossRefGoogle ScholarPubMed
Amin, MB, Trpkov, K, Lopez-Beltran, A, et al. Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol 2014;38:e20–34.CrossRefGoogle ScholarPubMed
Baldwin, L, Lee, AH, Al-Talib, RK, et al. Transitional cell carcinoma of the bladder mimicking lobular carcinoma of the breast: a discohesive variant of urothelial carcinoma. Histopathology 2005;46:50–6.CrossRefGoogle ScholarPubMed
Bannach, G, Grignon, D, Shum, D. Sarcomatoid transitional cell carcinoma vs pseudosarcomatous stromal reaction in bladder carcinoma: an immunohistochemical study. J Urol Pathol 1993;1:105–13.Google Scholar
Baydar, D, Amin, MB, Epstein, JI. Osteoclast-rich undifferentiated carcinomas of the urinary tract. Mod Pathol 2006;19:161–71.CrossRefGoogle ScholarPubMed
Bostwick, DG, Lopez-Beltran, A. Bladder Biopsy Interpretation. Washington DC: United Pathologists Press, 1999.Google Scholar
Chan, TY, Epstein, JI. Radiation or chemotherapy cystitis with “pseudocarcinomatous” features. Am J Surg Pathol 2004;28:909–13.CrossRefGoogle ScholarPubMed
Cheng, L, Cheville, JC, Neumann, RM, et al. Natural history of urothelial dysplasia of the bladder. Am J Surg Pathol 1999;23:443–7.CrossRefGoogle ScholarPubMed
Cheng, L, Cheville, JC, Neumann, RM, et al. Survival of patients with carcinoma in situ of the urinary bladder. Cancer 1999;85:2469–74.3.0.CO;2-U>CrossRefGoogle ScholarPubMed
Cheng, L, Davidson, DD, MacLennan, GT, et al. The origins of urothelial carcinoma. Expert Rev Anticancer Ther 2010;10(6):865–80.CrossRefGoogle ScholarPubMed
Cheng, L, MacLennan, GT, Lopez-Beltran, A. Histologic grading of urothelial carcinoma: a reappraisal. Hum Pathol 2012;43(12):2097–108.CrossRefGoogle ScholarPubMed
Cheng, L, MacLennan, GT, Zhang, S, et al. Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder. Cancer 2004;101:183–8.CrossRefGoogle ScholarPubMed
Cheng, L, Montironi, R, Davidson, DD, Lopez-Beltran, A. Staging and reporting of urothelial carcinoma of the urinary bladder. Mod Pathol 2009;22(2):S70–95.CrossRefGoogle ScholarPubMed
Cheng, L, Neumann, RM, Bostwick, DG. Papillary urothelial neoplasms of low malignant potential. Clinical and biologic implications. Cancer 1999;86:2102–8.3.0.CO;2-U>CrossRefGoogle ScholarPubMed
Cheng, L, Neumann, RM, Weaver, AL, et al. Predicting cancer progression in patients with stage T1 bladder carcinoma. J Clin Oncol 1999;17:3182–7.CrossRefGoogle ScholarPubMed
Cheng, L, Weaver, AL, Neumann, RM, et al. Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer. A new proposal. Cancer 1999;86:1035–43.3.0.CO;2-D>CrossRefGoogle ScholarPubMed
Cheng, L, Zhang, S, Alexander, R, et al. Sarcomatoid carcinoma of the urinary bladder: the final common pathway of urothelial carcinoma dedifferentiation. Am J Surg Pathol 2011;35(5):e34–46.CrossRefGoogle ScholarPubMed
Cheng, L, Zhang, S, MacLennan, GT, et al. Bladder cancer: translating molecular genetic insights into clinical practice. Hum Pathol 2011;42(4):455–81.CrossRefGoogle ScholarPubMed
Chow, N, Cairns, P, Eisenberger, CF, et al. Papillary urothelial hyperplasia is a clonal precursor to papillary transitional cell bladder cancer. Int J Cancer 2000;89:514–18.3.0.CO;2-H>CrossRefGoogle ScholarPubMed
Dalbagni, G, Herr, HW, Reuter, VE. Impact of a second transurethral resection on the staging of T1 bladder cancer. Urology 2002;60:822–4.CrossRefGoogle ScholarPubMed
Drew, PA, Furman, J, Civantos, F, et al. The nested variant of transitional cell carcinoma: an aggressive neoplasm with innocuous histology. Mod Pathol 1996;9:989–94.Google ScholarPubMed
Eble, JN, Sauter, G, Epstein, JI, et al. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press, 2004.Google Scholar
Eble, JN, Young, RH. Stromal osseous metaplasia in carcinoma of the bladder. J Urol 1991;145:823–5.CrossRefGoogle ScholarPubMed
Edge, SB, Byrd, DR, Compton, CC, et al. Cancer Staging Handbook from the AJCC Cancer Staging Manual, 7th edn. New York, NY: Springer-Verlag, 2010.Google Scholar
Epstein, JI, Amin, MB, Reuter, VR, et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998;22:1435–48.CrossRefGoogle ScholarPubMed
Farrow, GM, Utz, DC. Observation on microinvasive transitional cell carcinoma of the urinary bladder. Clin Oncol 1982;1:609–15.Google Scholar
Farrow, GM, Utz, D, Rife, C, et al. Clinical observations on sixty-nine cases of in situ carcinoma of the urinary bladder. Cancer Res 1977;37:2794–8.Google ScholarPubMed
Fujii, Y, Kawakami, S, Koga, F, et al. Long-term outcome of bladder papillary urothelial neoplasms of low malignant potential. BJU Int 2003;92:559–62.CrossRefGoogle ScholarPubMed
Gulley, ML, Amin, MB, Nicholls, JM, et al. Epstein-Barr virus is detected in undifferentiated nasopharyngeal carcinoma but not in lymphoepithelioma-like carcinoma of the urinary bladder. Hum Pathol 1995;26:1207–14.CrossRefGoogle Scholar
Gulmann, C, Paner, GP, Parakh, RS, et al. Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract. Hum Pathol 2013;44(2):164–72.CrossRefGoogle ScholarPubMed
Hartmann, A, Moser, K, Kriegmair, M, et al. Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma. Am J Pathol 1999;154:721–7.CrossRefGoogle ScholarPubMed
Hartmann, A, Rosner, U, Schlake, G, et al. Clonality and genetic divergence in multifocal low-grade superficial urothelial carcinoma as determined by chromosome 9 and p53 deletion analysis. Lab Invest 2000;80:709–18.CrossRefGoogle ScholarPubMed
Hodges, KB, Lopez-Beltran, A, Emerson, RE, et al. Clinical utility of immunohistochemistry in the diagnoses of urinary bladder neoplasia. Appl Immunohistochem Mol Morphol 2010;18:401–10.CrossRefGoogle ScholarPubMed
Hodges, KB, Lopez-Beltran, A, MacLennan, GT, Montironi, R, Cheng, L. Urothelial lesions with inverted growth patterns: histogenesis, molecular genetic findings, differential diagnosis and clinical management. BJU Int 2011;107(4):532–7.CrossRefGoogle ScholarPubMed
Holmang, S, Hedelin, H, Anderstrom, C, et al. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol 1995;153:1823–7.CrossRefGoogle ScholarPubMed
Huang, Q, Chu, PG, Lau, SK, et al. Urothelial carcinoma of the urinary bladder with a component of acinar/tubular type differentiation simulating prostatic adenocarcinoma. Hum Pathol 2004;35:769–73.CrossRefGoogle ScholarPubMed
Jewett, HJ. Carcinoma of the bladder: influence of depth of infiltration on the 5-year results following complete extirpation of the primary growth. J Urol 1952;67:672–80.CrossRefGoogle ScholarPubMed
Jimenez, RE, Gheiler, E, Oskanian, P, et al. Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival. Am J Surg Pathol 2000;24:980–7.CrossRefGoogle ScholarPubMed
Jones, EC, Young, RH. Myxoid and sclerosing sarcomatoid transitional cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 25 cases. Mod Pathol 1997;10:908–16.Google ScholarPubMed
Jones, TD, Cheng, L. Papillary urothelial neoplasm of low malignant potential: evolving terminology and concepts. J Urol 2006;175:1995–2003.CrossRefGoogle ScholarPubMed
Jones, TD, Wang, M, Eble, JN, et al. Molecular evidence supporting field effect in urothelial carcinogenesis. Clin Cancer Res 2005;11:6512–19.CrossRefGoogle ScholarPubMed
Kakizoe, T, Matumoto, K, Nishio, Y, et al. Significance of carcinoma in situ and dysplasia association with bladder cancer. J Urol 1985;133:395–8.CrossRefGoogle ScholarPubMed
Kawachi, Y, Ishi, K. Inverted transitional cell carcinoma of the ureter. Int J Urol 1996;3:313–15.CrossRefGoogle ScholarPubMed
Keck, B, Stoehr, R, Wach, S, et al. The plasmacytoid carcinoma of the bladder – rare variant of aggressive urothelial carcinoma. Int J Cancer 2011;129(2):346–54.CrossRefGoogle ScholarPubMed
Kiemeney, L, Witjes, J, Heibroek, R, et al. Dysplasia in normal-looking urothelium increases the risk of tumour progression in primary superficial bladder cancer. Eur J Cancer 1994;30A:1621–5.Google ScholarPubMed
Kirkali, Z, Chan, T, Manoharan, M, et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 2005;66:4–34.CrossRefGoogle ScholarPubMed
Koss, LG, Tiamson, EM, Robbins, MA. Mapping cancerous and precancerous bladder changes. A study of the urothelium in ten surgically removed bladders. JAMA 1974;227:281–6.CrossRefGoogle ScholarPubMed
Kunze, E, Francksen, B, Schulz, H. Expression of MUC5AC apomucin in transitional cell carcinomas of the urinary bladder and its possible role in the development of mucus-secreting adenocarcinomas. Virchows Arch 2001;439:609–15.CrossRefGoogle ScholarPubMed
Lahoti, C, Schinella, R, Rangwala, AF, et al. Carcinosarcoma of urinary bladder: report of 5 cases with immunohistologic study. Urology 1994;43:389–93.CrossRefGoogle ScholarPubMed
Lamm, K. Chondroid and osseous metaplasia in carcinoma of the bladder. J Urol Pathol 1995;3:255–62.Google Scholar
Leblanc, B, Duclos, AJ, Benard, F, et al. Long-term followup of initial Ta grade 1 transitional cell carcinoma of the bladder. J Urol 1999;162:1946–60.CrossRefGoogle ScholarPubMed
Lopez-Beltran, A. Bladder cancer: clinical and pathological profile. Scand J Urol Nephrol Suppl 2008;(218):95–109.CrossRefGoogle ScholarPubMed
Lopez-Beltran, A. Rare lesions and tumors of the urinary bladder. Selected issues. Tumori 2012;98(2):274–7.CrossRefGoogle ScholarPubMed
Lopez-Beltran, A, Bassi, P, Pavone-Macaluso, M, et al. Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis. Eur Urol 2004;45:257–66.CrossRefGoogle ScholarPubMed
Lopez-Beltran, A, Blanca, A, Montironi, R, Cheng, L, Regueiro, JC. Pleomorphic giant cell carcinoma of the urinary bladder. Hum Pathol 2009;40(10):1461–6.CrossRefGoogle ScholarPubMed
Lopez-Beltran, A, Cheng, L. Stage pT1 bladder carcinoma: diagnostic criteria, pitfalls and prognostic significance. Pathology 2003;35:484–91.CrossRefGoogle ScholarPubMed
Lopez-Beltran, A, Cheng, L. Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications. Hum Pathol 2006;37:1371–88.Google ScholarPubMed
Lopez-Beltran, A, Cheng, L, Comperat, E, et al. Large cell undifferentiated carcinoma of the urinary bladder. Pathology 2010;42(4):364–8.CrossRefGoogle ScholarPubMed
Lopez-Beltran, A, Cheng, L, Montironi, R, et al. Clinicopathological characteristics and outcome of nested carcinoma of the urinary bladder. Virchows Arch 2014;465(2):199–205.CrossRefGoogle Scholar
Lopez-Beltran, A, Luque, RJ, Mazzuchelli, R, et al. Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer. J Clin Pathol 2002;55:641–7.CrossRefGoogle ScholarPubMed
Lopez-Beltran, A, Martin, J, Garcia, J, et al. Squamous and glandular differentiation in urothelial bladder carcinomas. Histopathology, histochemistry and immunohistochemical expression of carcinoembryonic antigen. Histol Histopathol 1988;3:63–8.Google ScholarPubMed
Lopez-Beltran, A, Montironi, R. Non-invasive urothelial neoplasms: according to the most recent WHO classification. Eur Urol 2004;46:170–6.Google Scholar
Lopez-Beltran, A, Montironi, R, Blanca, A, Cheng, L. Invasive micropapillary urothelial carcinoma of the bladder. Hum Pathol 2010;41(8):1159–64.CrossRefGoogle ScholarPubMed
Lopez-Beltran, A, Montironi, R, Cheng, L. Microcystic urothelial carcinoma: morphology, immunohistochemistry and clinical behaviour. Histopathology 2014,64:872–9.CrossRefGoogle ScholarPubMed
Lopez-Beltran, A, Pacelli, A, Rothenberg, HJ, et al. Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases. J Urol 1998;159:1497–503.CrossRefGoogle ScholarPubMed
Lopez-Beltran, A, Requena, MJ, Alvarez-Kindelan, J, et al. Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry. J Clin Pathol 2007;60:332–5.Google ScholarPubMed
Lopez-Beltran, A, Requena, MJ, Luque, RJ, et al. Cyclin D3 expression in primary Ta/T1 bladder cancer. J Pathol 2006;209:106–13.CrossRefGoogle ScholarPubMed
Lopez-Beltran, A, Requena, MJ, Montironi, R, Blanca, A, Cheng, L. Plasmacytoid urothelial carcinoma of the bladder. Hum Pathol 2009;40(7):1023–8.CrossRefGoogle ScholarPubMed
Lopez-Beltran, A, Sauter, G, Gasser, T, et al. Urothelial tumors: infiltrating urothelial carcinoma. In Eble, JN, Sauter, G, Epstein, JI, Sesterhenn, I, eds. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs. Lyon: IARC Press, 2004.Google Scholar
Mahadevia, PS, Koss, LG, Tar, IJ. Prostatic involvement in bladder cancer. Prostate mapping in 20 cystoprostatectomy specimens. Cancer 1986;58:2096–102.3.0.CO;2-0>CrossRefGoogle ScholarPubMed
Malmstrom, PU, Bush, C, Norlen, BJ. Recurrence, progression, and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up. Scand J Urol Nephrol 1987;21:185–95.CrossRefGoogle ScholarPubMed
Martin, JE, Jenkins, BJ, Zuk, RJ, et al. Human chorionic gonadotrophin expression and histological findings as predictors of response to radiotherapy in carcinoma of the bladder. Virchows Arch A Pathol Anat Histopathol 1989;414:273–7.CrossRefGoogle ScholarPubMed
Mazzucchelli, R, Cheng, L, Lopez-Beltran, A, Scarpelli, M, Montironi, R. Classification and grading of noninvasive and invasive neoplasms of the urothelium. Anal Quant Cytol Histol 2012;34(3):111–19.Google ScholarPubMed
Mazzucchelli, R, Cheng, L, Lopez-Beltran, A, Scarpelli, M, Montironi, R. Clinicopathological significance of lymphovascular invasion in urothelial carcinoma. Anal Quant Cytopathol Histopathol 2012;34(4):173–9.Google ScholarPubMed
McKenney, JK, Desai, S, Cohen, C, et al. Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens. Am J Surg Pathol 2001;25:1074–8.CrossRefGoogle ScholarPubMed
McKenney, JK, Gomez, JA, Desai, S, et al. Morphologic expressions of urothelial carcinoma in situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion. Am J Surg Pathol 2001;25:356–62.CrossRefGoogle Scholar
Melamed, M, Voutsa, N, Grabstald, H. Natural history and clinical behavior of in situ carcinoma of the human urinary bladder. Cancer 1964;17:1533–45.3.0.CO;2-7>CrossRefGoogle ScholarPubMed
Montironi, R, Cheng, L, Lopez-Beltran, A, et al. Inverted (endophytic) noninvasive lesions and neoplasms of the urothelium: the Cinderella group has yet to be fully exploited. Eur Urol 2011;59(2):225–30.CrossRefGoogle ScholarPubMed
Montironi, R, Lopez-Beltran, A. The 2004 WHO classification of bladder tumors: a summary and commentary. Int J Surg Pathol 2005;13:143–53.CrossRefGoogle ScholarPubMed
Montironi, R, Lopez-Beltran, A, Mazzuchelli, R, et al. Classification and grading of the non-invasive neoplasms: recent advances and controversies. J Clin Pathol 2003;56:91–5.CrossRefGoogle ScholarPubMed
Montironi, R, Scarpelli, M, Mazzucchelli, R, et al. Subvisual changes in chromatin organization state are detected by karyometry in the histologically normal urothelium in patients with synchronous papillary carcinoma. Hum Pathol 2003;34:893–901.CrossRefGoogle ScholarPubMed
Mostofi, FK, Sobin, LH, Torloni, H. Histological Typing of Urinary Bladder Tumours. Geneva: World Health Organization, 1973.Google Scholar
Murphy, WM, Deanna, DG. The nested variant of transitional cell carcinoma: a neoplasm resembling proliferation of Brunn’s nests. Mod Pathol 1992;5:240–3.Google ScholarPubMed
Offersen, BV, Knap, MM, Marcussen, N, et al. Intense inflammation in bladder carcinoma is associated with angiogenesis and indicates good prognosis. Br J Cancer 2002;87:1422–30.CrossRefGoogle ScholarPubMed
Ogishima, T, Kawachi, Y, Saito, A, et al. Sarcomatoid carcinoma and carcinosarcoma of the urinary bladder. Int J Urol 2002;9:354–8.CrossRefGoogle ScholarPubMed
Oliva, E, Amin, MB, Jimenez, R, et al. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems. Am J Surg Pathol 2002;26:190–7.CrossRefGoogle ScholarPubMed
Omeroglu, A, Paner, GP, Wojcik, EM, et al. A carcinosarcoma/sarcomatoid carcinoma arising in a urinary bladder diverticulum. Arch Pathol Lab Med 2002;126:853–5.CrossRefGoogle Scholar
Orozco, R, Martin, A, Murphy, W. Carcinoma in situ of the urinary bladder: clues to host involvement in human carcinogenesis. Cancer 1994;74:115–22.3.0.CO;2-R>CrossRefGoogle ScholarPubMed
Owens, CL, Epstein, JI. Significance of denuded urothelium in papillary urothelial lesions. Am J Surg Pathol 2007;31:298–303.CrossRefGoogle ScholarPubMed
Paner, GP, Cox, RM, Richards, K, et al. Pseudoangiosarcomatous urothelial carcinoma of the urinary bladder. Am J Surg Pathol 2014;38(9):1251–9.CrossRefGoogle ScholarPubMed
Paner, GP, McKenney, JK, Barkan, GA, et al. Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls. Am J Surg Pathol 2011;35:787–98.CrossRefGoogle Scholar
Pant-Purohit, M, Lopez-Beltran, A, Montironi, R, MacLennan, GT, Cheng, L. Small cell carcinoma of the urinary bladder. Histol Histopathol 2010;25(2):217–21.Google ScholarPubMed
Parwani, AV, Herawi, M, Volmar, K, et al. Urothelial carcinoma with rhabdoid features: report of 6 cases. Hum Pathol 2006;37:168–72.CrossRefGoogle ScholarPubMed
Patriarca, C, Colecchia, M, Lopez-Beltran, A, et al. Nest-like features in bladder, simulating the nested variant of urothelial carcinoma. Int J Surg Pathol 2009;19(1):11–19.CrossRefGoogle ScholarPubMed
Pich, A, Chiusa, L, Formiconi, A, et al. Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinomas of the bladder. Am J Surg Pathol 2001;25:1528–33.CrossRefGoogle ScholarPubMed
Ro, JY, Ayala, AG, el-Naggar, A. Muscularis mucosa of urinary bladder. Importance for staging and treatment. Am J Surg Pathol 1987;11:668–73.CrossRefGoogle ScholarPubMed
Samaratunga, H, Khoo, K. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study. Histopathology 2004;45:55–64.CrossRefGoogle ScholarPubMed
Samaratunga, H, Makarov, DV, Epstein, JN. Comparison of WHO/IUP and WHO classification of non-invasive papillary urothelial neoplasms for risk of progression. Urology 2002;15:315–19.Google Scholar
Sangoi, AR, Beck, AH, Amin, MB, et al. Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists. Am J Surg Pathol 2010;34(9):1367–76.CrossRefGoogle ScholarPubMed
Schmitz-Drager, BJ, van Roeyen, CR, Grimm, MO, et al. P53 accumulation in precursor lesions and early stages of bladder cancer. World J Urol 1994;12:79–83.CrossRefGoogle ScholarPubMed
Shanks, JH, Iczkowski, KA. Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics. Histopathology 2009;54(7):885–900.CrossRefGoogle ScholarPubMed
Shirai, T, Fukushima, S, Hirose, M, et al. Epithelial lesions of the urinary bladder in 313 autopsy cases. Jpn J Cancer Res 1987;78:1073–80.Google ScholarPubMed
Sidransky, EA, Frost, P, von Eschenbach, A, et al. Clonal origin of bladder cancer. N Engl J Med 1992;326:737–40.CrossRefGoogle ScholarPubMed
Spruck, CH 3rd, Ohneseit, PF, Gonzalez-Zulueta, M, et al. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 1994;54:784–8.Google ScholarPubMed
Sung, MT, Wang, M, MacLennan, G, et al. Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation. J Pathol 2007;211:420–30.CrossRefGoogle ScholarPubMed
Talbert, ML, Young, RH. Carcinomas of the urinary bladder with deceptively benign-appearing foci. A report of three cases. Am J Surg Pathol 1989;13:374–81.CrossRefGoogle Scholar
Tamas, EF, Epstein, JI. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains. Am J Surg Pathol 2007;31:390–7.CrossRefGoogle ScholarPubMed
Tamas, EF, Nielsen, ME, Schoenberg, MP, et al. Lymphoepithelioma-like carcinoma of the urinary tract: a clinicopathological study of 30 pure and mixed cases. Mod Pathol 2007;20:828–34.CrossRefGoogle ScholarPubMed
van Rhijn, BW, Lurkin, I, Radvanyi, F, et al. The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate. Cancer Res 2001;61:1265–8.Google Scholar
van Rhijn, BW, van der Kwast, TH, Vis, AN, et al. FGFR3 and p53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma. Cancer Res 2004;64:1911–14.CrossRefGoogle ScholarPubMed
Volmar, KE, Chan, TY, De Marzo, AM, et al. Florid von Brunn nests mimicking urothelial carcinoma: a morphologic and immunohistochemical comparison to the nested variant of urothelial carcinoma. Am J Surg Pathol 2003;27:1243–52.CrossRefGoogle Scholar
Wagner, U, Sauter, G, Moch, H, et al. Patterns of p53, erbB-2, and EGF-r expression in premalignant lesions of the urinary bladder. Hum Pathol 1995;26:970–8.CrossRefGoogle ScholarPubMed
Wasco, MJ, Daignault, S, Zhang, Y, et al. Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection. Urology 2007;70:69–74.CrossRefGoogle ScholarPubMed
Williamson, SR, Lopez-Beltran, A, MacLennan, GT, Montironi, R, Cheng, L. Unique clinicopathologic and molecular characteristics of urinary bladder tumors in children and young adults. Urol Oncol 2013;31(4):414–26.CrossRefGoogle ScholarPubMed
Williamson, SR, Wang, M, Montironi, R, et al. Molecular characteristics of urothelial neoplasms in children and young adults: a subset of tumors from young patients harbors chromosomal abnormalities but not FGFR3 or TP53 gene mutations. Mod Pathol 2014;27(11):1540–8.CrossRefGoogle ScholarPubMed
Williamson, SR, Zhang, S, Lopez-Beltran, A, et al. Telomere shortening distinguishes inverted urothelial neoplasms. Histopathology 2013;62(4):595–601.CrossRefGoogle ScholarPubMed
Williamson, SR, Zhang, S, Lopez-Beltran, A, et al. Lymphoepithelioma-like carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, and molecular features. Am J Surg Pathol 2011;35(4):474–83.CrossRefGoogle ScholarPubMed
Yoshimura, I, Kudoh, J, Saito, S, et al. p53 gene mutation in recurrent superficial bladder cancer. J Urol 1995;153:1711–15.CrossRefGoogle ScholarPubMed
Younes, M, Sussman, J, True, LD. The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder. Cancer 1990;66:543–8.3.0.CO;2-R>CrossRefGoogle ScholarPubMed
Young, RH, Oliva, E. Transitional cell carcinomas of the urinary bladder that may be underdiagnosed. A report of four invasive cases exemplifying the homology between neoplastic and non-neoplastic transitional cell lesions. Am J Surg Pathol 1996;20:1448–54.CrossRefGoogle ScholarPubMed
Zhong, H, George, S, Kauffman, E, et al. Clinicopathologic characterization of intradiverticular carcinoma of urinary bladder – a study of 22 cases from a single cancer center. Diagn Pathol 2014;9(1):222.CrossRefGoogle ScholarPubMed
Zhong, M, Tian, W, Zhuge, J, et al. Distinguishing nested variants of urothelial carcinoma from benign mimickers by TERT promoter mutation. Am J Surg Pathol 2015;39(1):127–31.CrossRefGoogle ScholarPubMed
Further reading
Alexander, RE, Lopez-Beltran, A, Montironi, R, et al. KRAS mutation is present in a small subset of primary urinary bladder adenocarcinomas. Histopathology 2012;61(6):1036–42.CrossRefGoogle Scholar
Alexander, RE, Montironi, R, Lopez-Beltran, A, et al. EGFR alterations and EML4-ALK rearrangement in primary adenocarcinoma of the urinary bladder. Mod Pathol 2014;27(1):107–12.CrossRefGoogle ScholarPubMed
Alexander, RE, Williamson, SR, Richey, J, et al. The expression patterns of p53 and p16 and an analysis of a possible role of HPV in primary adenocarcinoma of the urinary bladder. PLoS One 2014;9(4):e95724.CrossRefGoogle Scholar
Amin, MB, Trpkov, K, Lopez-Beltran, A, et al. Best practices recommendations in the application of immunohistochemistry in the bladder lesions: Report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol 2014;38:e20–34.CrossRefGoogle ScholarPubMed
Bollito, ER, Pacchioni, D, Lopez-Beltran, A, et al. Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumors of the urinary bladder. Anal Quant Cytol Histol 2005;27:218–24.Google ScholarPubMed
Cheng, L, Montironi, R, Bostwick, DG. Villous adenoma of the urinary tract: a report of 23 cases, including 8 with coexistent adenocarcinoma. Am J Surg Pathol 1999;23:764–71.CrossRefGoogle ScholarPubMed
Epstein, JI, Egevad, L, Humphrey, PA, Montironi, R. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol 2014;38:e6–19.CrossRefGoogle ScholarPubMed
Grignon, D, Ro, J, Ayala, A, et al. Primary adenocarcinoma of the urinary bladder: a clinicopathologic analysis of 72 cases. Cancer 1990;67:2165–72.Google Scholar
Herawi, M, Drew, PA, Pan, CC, Epstein, JI. Clear cell adenocarcinoma of the bladder and urethra: cases diffusely mimicking nephrogenic adenoma. Hum Pathol 2010;41(4):594–601.CrossRefGoogle ScholarPubMed
Hodges, KB, Lopez-Beltran, A, Emerson, RE, Montironi, R, Cheng, L. Clinical utility of immunohistochemistry in the diagnoses of urinary bladder neoplasia. Appl Immunohistochem Mol Morphol 2010;18(5):401–10.CrossRefGoogle ScholarPubMed
Liu, H, Shi, J, Wilkerson, ML, Lin, F. Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas. Am J Clin Pathol 2012;138:57–64.CrossRefGoogle ScholarPubMed
Lopez-Beltran, A, Luque, RJ, Quintero, A, et al. Hepatoid adenocarcinoma of the urinary bladder. Virchows Arch 2003;442:381–7.CrossRefGoogle ScholarPubMed
Oliva, E, Amin, MB, Jimenez, R, et al. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems. Am J Surg Pathol 2002;26:190–7.CrossRefGoogle ScholarPubMed
Panarelli, NC, Yantiss, RK, Yeh, MM, Liu, Y, Chen, YT. Tissue-specific cadherin CDH17 is a useful marker of gastrointestinal adenocarcinomas with higher sensitivity than CDX2. Am J Clin Pathol 2012;138:211–22.CrossRefGoogle ScholarPubMed
Paner, GP, McKenney, JK, Barkan, GA, et al. Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls. Am J Surg Pathol 2011;35(6):787–98.CrossRefGoogle Scholar
Rao, Q, Williamson, SR, Lopez-Beltran, A, et al. Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers. Mod Pathol 2013;26(5):725–32.CrossRefGoogle ScholarPubMed
Shih, CM, Huang, CT, Chi, CH, Lin, JW, Pan, CC. CA125-producing clear cell adenocarcinoma arising from the upper ureter and renal pelvis. J Chin Med Assoc 2010;73(1):40–3.CrossRefGoogle ScholarPubMed
Suh, N, Yang, XJ, Tretiakova, MS, Humphrey, PA, Wang, HL. Value of CDX2, villin, and alpha-methylacyl coenzyme A racemase immunostains in the distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Mod Pathol 2005;18;1217–22.CrossRefGoogle ScholarPubMed
Tamboli, P, Mohsin, SK, Hailemariam, S, Amin, MB. Colonic adenocarcinoma metastatic to the urinary tract versus primary tumors of the urinary tract with glandular differentiation: a report of 7 cases and investigation using a limited immunohistochemical panel. Arch Pathol Lab Med 2002;126;1057–63.CrossRefGoogle Scholar
Tong, GX, Weeden, EM, Hamele-Bena, D, et al. Expression of PAX8 in nephrogenic adenoma and clear cell adenocarcinoma of the lower urinary tract: evidence of related histogenesis? Am J Surg Pathol 2008;32(9):1380–7.CrossRefGoogle ScholarPubMed
Wang, HL, Lu, DW, Yerian, LM, et al. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Am J Surg Pathol 2001;25:1380–7.CrossRefGoogle ScholarPubMed
Williamson, SR, Lopez-Beltran, A, Montironi, R, Cheng, L. Glandular lesions of the urinary bladder: clinical significance and differential diagnosis. Histopathology 2011;58(6):211–34.CrossRefGoogle ScholarPubMed
Further reading
Alexander, RE, Lopez-Beltran, A, Montironi, R, et al. KRAS mutation is present in a small subset of primary urinary bladder adenocarcinomas. Histopathology 2012;61(6):1036–42.CrossRefGoogle Scholar
Amin, MB, Smith, SC, Eble, JN, et al. Glandular neoplasms of the urachus: a report of 55 cases emphasizing mucinous cystic tumors with proposed classification. Am J Surg Pathol 2014;38:1033–45.CrossRefGoogle ScholarPubMed
Cheng, L, Montironi, R, Bostwick, DG. Villous adenoma of the urinary tract: a report of 23 cases, including 8 with coexistent adenocarcinoma. Am J Surg Pathol 1999;23:764–71.CrossRefGoogle ScholarPubMed
Gopalan, A, Sharp, DS, Fine, SW, et al. Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation. Am J Surg Pathol 2009;33(5):659–68.CrossRefGoogle ScholarPubMed
Huang, HY, Ko, SF, Chuang, JH, et al. Primary yolk sac tumor of the urachus. Arch Pathol Lab Med 2002;126:1106–9.CrossRefGoogle ScholarPubMed
Hutchinson, L, Paner, GP, Tomaszewicz, K, et al. KRAS is mutated in a subset of mucinous type urachal adenocarcinomas. Mod Pathol 2012;25(S2):214A.Google Scholar
Lopez-Beltran, A, Nogales, F, Donne, CH, et al. Adenocarcinoma of the urachus showing extensive calcification and stromal osseous metaplasia. Urol Int 1994;53:110–13.CrossRefGoogle ScholarPubMed
Paner, GP, Barkan, GA, Mehta, V, et al. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis. Am J Surg Pathol 2012;36:432–42.CrossRefGoogle ScholarPubMed
Paner, GP, McKenney, JK, Barkan, GA, et al. Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls. Am J Surg Pathol 2011;35:787–98.CrossRefGoogle Scholar
Sheldon, CA, Clayman, RV, Gonzalez, R, Williams, RD, Fraley, EE. Malignant urachal lesions. J Urol 1984;131(1):1–8.CrossRefGoogle ScholarPubMed
Tareen, F, McDowell, DT, O’Sullivan, M, Mortell, A. Urachal carcinoid – a new presentation. Eur J Pediatr Surg 2013;23(3):e1–2.CrossRefGoogle ScholarPubMed
Further reading
Abdulamir, AS, Hafidh, RR, Kadhim, HS, et al. Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumors. J Exp Clin Cancer Res 2009;28:27.CrossRefGoogle ScholarPubMed
Alexander, RE, Hu, Y, Kum, JB, et al. p16 expression is not associated with human papillomavirus in urinary bladder squamous cell carcinoma. Mod Pathol 2012;15(11):1526–33.Google Scholar
Cioffi-Lavina, M, Chapman-Fredricks, J, Gomez-Fernandez, C, et al. p16 expression in squamous cell carcinomas of cervix and bladder. Appl Immunohistochem Mol Morphol 2010;18:344–7.CrossRefGoogle ScholarPubMed
Gulmann, C, Paner, GP, Parakh, RS, et al. Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract. Hum Pathol 2013;44(2):164–72.CrossRefGoogle ScholarPubMed
Huang, W, Williamson, SR, Rao, Q, et al. Novel markers of squamous differentiation in the urinary bladder. Hum Pathol 2013;44:1989–97.CrossRefGoogle ScholarPubMed
Lopez-Beltran, A, Requena, MJ, Alvarez-Kindelan, J, et al. Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry. J Clin Pathol 2007;60:332–5.Google ScholarPubMed
Nakazawa, K, Murata, S-I, Yuminamochi, T, et al. p16(INK4a) expression analysis as an ancillary tool for cytologic diagnosis of urothelial carcinoma. Am J Clin Pathol 2009;132:776–84.CrossRefGoogle ScholarPubMed
Vakar-López, F, Abrams, J. Basaloid squamous cell carcinoma occurring in the urinary bladder. Arch Pathol Lab Med 2000;124:455–9.CrossRefGoogle ScholarPubMed
Zhong, H, George, S, Kauffman, E, et al. Clinicopathologic characterization of intradiverticular carcinoma of urinary bladder – a study of 22 cases from a single cancer center. Diagn Pathol 2014;9(1):222.CrossRefGoogle ScholarPubMed
Further reading
Almeida, M, Canas-Marques, R, Lopez-Beltran, A, et al. Small cell carcinoma of the bladder associated with schistosomiasis: a case report. Anal Quant Cytopathol Histpathol 2014;36(6):339–44.Google ScholarPubMed
Baydar, DE, Tasar, C. Carcinoid tumor in the urinary bladder: unreported features. Am J Surg Pathol 2011;35(11):1754–7.CrossRefGoogle ScholarPubMed
Chen, YB, Epstein, JI. Primary carcinoid tumors of the urinary bladder and prostatic urethra: a clinicopathologic study of 6 cases. Am J Surg Pathol 2011;35(3):442–6.CrossRefGoogle ScholarPubMed
Cheng, L, Jones, TD, McCarthy, RP, et al. Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma. Am J Pathol 2005;166:1533–9.CrossRefGoogle ScholarPubMed
Cheng, L, Pan, CX, Yang, XJ, et al. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer 2004;101:957–62.CrossRefGoogle ScholarPubMed
Coelho, HM, Pereira, BA, Caetano, PA. Large cell neuroendocrine carcinoma of the urinary bladder: case report and review. Curr Urol 2013;7(3):155–9.Google ScholarPubMed
Flamminio, F, Tosi, AL, Fellegara, G. Crushing artifacts resulting in small blue cellular clusters that simulate small cell carcinoma. Int J Surg Pathol 2011;19(4):487–91.CrossRefGoogle ScholarPubMed
Iczkowski, KA, Shanks, JH, Allsbrook, WC, et al. Small cell carcinoma of urinary bladder is differentiated from urothelial carcinoma by chromogranin expression, absence of CD44 variant 6 expression, a unique pattern of cytokeratin expression, and more intense gamma-enolase expression. Histopathology 1999;35:150–6.CrossRefGoogle ScholarPubMed
Jones, TD, Kernek, KM, Yang, XJ, et al. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases. Hum Pathol 2005;36:718–23.CrossRefGoogle ScholarPubMed
Kaushik, D, Frank, I, Boorjian, SA, et al. Long-term results of radical cystectomy and role of adjuvant chemotherapy for small cell carcinoma of the bladder. Int J Urol 2015;22(6): 549–54.CrossRefGoogle ScholarPubMed
Lee, KH, Ryu, SB, Lee, MC, et al. Primary large cell neuroendocrine carcinoma of the urinary bladder. Pathol Int 2006;56:688–93.CrossRefGoogle ScholarPubMed
Martignoni, G, Eble, JN. Carcinoid tumors of the urinary bladder. Immunohistochemical study of 2 cases and review of the literature. Arch Pathol Lab Med 2003;127:e22–4.CrossRefGoogle ScholarPubMed
Mazzucchelli, R, Morichetti, D, Lopez-Beltran, A, et al. Neuroendocrine tumors of the urinary system and male genital organs: clinical significance. BJU Int 2009;103(11):1464–70.CrossRefGoogle ScholarPubMed
Pan, CX, Yang, XJ, Lopez-Beltran, A, et al. c-kit expression in small cell carcinoma of the urinary bladder: prognostic and therapeutic implications. Mod Pathol 2005;18:320–3.CrossRefGoogle ScholarPubMed
Pant-Purohit, M, Lopez-Beltran, A, Montironi, R, MacLennan, GT, Cheng, L. Small cell carcinoma of the urinary bladder. Histol Histopathol 2010;25(2):217–21.Google ScholarPubMed
Pusiol, T, Morichetti, D, Zorzi, MG. “Pure” primary large cell neuroendocrine carcinoma of the urinary bladder: case report, literature review and diagnostic criteria. Pathologica 2014;106(2):82–5.Google ScholarPubMed
Shatagopam, K, Kaimakliotis, HZ, Cheng, L, Koch, MO. Genitourinary small cell malignancies: prostate and bladder. Future Oncol 2015;11(3):479–88.CrossRefGoogle ScholarPubMed
Wang, X, Jones, TD, MacLennan, GT, et al. p53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications. Anticancer Res 2005;25:2001–4.Google ScholarPubMed
Wang, X, MacLennan, GT, Lopez-Beltran, A, et al. Small cell carcinoma of the urinary bladder: histogenesis, genetics, diagnosis, biomarkers, treatment, and prognosis. Appl Immunohistochem Mol Morphol 2007;15:8–18.CrossRefGoogle ScholarPubMed
Wang, X, Zhang, S, MacLennan, GT, et al. Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder. Clin Cancer Res 2007;13:953–7.Google ScholarPubMed
Williamson, SR, Zhang, S, Yao, JL, et al. ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin. Mod Pathol 2011;24(8):1120–7.CrossRefGoogle ScholarPubMed
Zheng, X, Zhuge, J, Bezerra, SM, et al. High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins. J Hematol Oncol 2014;7:47.CrossRefGoogle Scholar
Zhong, H, George, S, Kauffman, E, et al. Clinicopathologic characterization of intradiverticular carcinoma of urinary bladder – a study of 22 cases from a single cancer center. Diagn Pathol 2014;9(1):222.CrossRefGoogle ScholarPubMed
Zozumi, M, Nakai, M, Matsuda, I, et al. Primary carcinoid tumor of the urinary bladder with prominent subnuclear eosinophilic granules. Pathol Res Pract 2012;208(2):109–12.CrossRefGoogle ScholarPubMed
Further reading
Amin, MB, Trpkov, K, Lopez-Beltran, A, et al. Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol 2014;38(8):e20–34.CrossRefGoogle ScholarPubMed
Cheng, L, Davison, DD, Adams, J, et al. Biomarkers in bladder cancer: translational and clinical implications. Crit Rev Oncol Hematol 2014;89(1):73–111.CrossRefGoogle ScholarPubMed
Cheng, L, Foster, SR, MacLennan, GT, et al. Inflammatory myofibroblastic tumors of the genitourinary tract–single entity or continuum? J Urol 2008;180(4):1235–40.CrossRefGoogle ScholarPubMed
Choi, E, Williamson, SR, Montironi, R, et al. Inflammatory myofibroblastic tumour of the urinary bladder: the role of immunoglobulin G4 and the comparison of two immunohistochemical antibodies and fluorescence in-situ hybridization for the detection of anaplastic lymphoma kinase alterations. Histopathology 2015;67(1):20–38.CrossRefGoogle ScholarPubMed
Freeman, A, Geddes, N, Munson, P, et al. Anaplastic lymphoma kinase (ALK 1) staining and molecular analysis in inflammatory myofibroblastic tumours of the bladder: a preliminary clinicopathological study of nine cases and review of the literature. Mod Pathol 2004;17:765–71.CrossRefGoogle ScholarPubMed
Fuller, TW, Dangle, P, Reese, JN, et al. Inflammatory myofibroblastic tumor of the bladder masquerading as eosinophilic cystitis: case report and review of the literature. Urology 2015;85(4):921–3.CrossRefGoogle ScholarPubMed
Harik, LR, Merino, C, Coindre, JM, et al. Pseudosarcomatous myofibroblastic proliferations of the bladder: a clinicopathologic study of 42 cases. Am J Surg Pathol 2006;30:787–94.CrossRefGoogle ScholarPubMed
Kapusta, LR, Weiss, MA, Ramsay, J, Lopez-Beltran, A, Srigley, JR. Inflammatory myofibroblastic tumors of the kidney: a clinicopathologic and immunohistochemical study of 12 cases. Am J Surg Pathol 2003;27(5):658–66.CrossRefGoogle ScholarPubMed
Lopez-Beltran, A, Lopez-Ruiz, J, Vicioso, L. Inflammatory pseudotumor of the urinary bladder. A clinicopathological analysis of two cases. Urol Int 1995;55:173–6.CrossRefGoogle ScholarPubMed
Lott, S, Lopez-Beltran, A, MacLennan, GT, et al. Soft tissue tumors of the urinary bladder, part I: myofibroblastic proliferations, benign neoplasms, and tumors of uncertain malignant potential. Hum Pathol 2007;38:807–23.CrossRefGoogle ScholarPubMed
Montgomery, EA, Shuster, DD, Burkart, AL, et al. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma. Am J Surg Pathol 2006;30:1502–12.CrossRefGoogle Scholar
Paner, GP, Cox, RM, Richards, K, et al. Pseudoangiosarcomatous urothelial carcinoma of the urinary bladder. Am J Surg Pathol 2014;38(9):1251–9.CrossRefGoogle ScholarPubMed
Proppe, KH, Scully, RE, Rosai, J. Postoperative spindle cell nodules of genitourinary tract resembling sarcomas. A report of eight cases. Am J Surg Pathol 1984;8:101–8.CrossRefGoogle ScholarPubMed
Ro, JY, el-Naggar, AK, Amin, MB, et al. Inflammatory pseudotumor of the urinary bladder. Am J Surg Pathol 1993;17:1193–4.CrossRefGoogle ScholarPubMed
Shanks, JH, Iczkowski, KA. Spindle cell lesions of the bladder and urinary tract. Histopathology 2009;55(5):491–504.CrossRefGoogle ScholarPubMed
Tsuzuki, T, Magi-Galluzzi, C, Epstein, JI. ALK-1 expression in inflammatory myofibroblastic tumor of the urinary bladder. Am J Surg Pathol 2004;28:1609–14.CrossRefGoogle ScholarPubMed
Watanabe, K, Baba, K, Saito, A, et al. Pseudosarcomatous myofibroblastic tumor and myosarcoma of the urogenital tract. Arch Pathol Lab Med 2001;125:1070–3.CrossRefGoogle ScholarPubMed
Westfall, DE, Folpe, AL, Paner, GP, et al. Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder. Am J Surg Pathol 2009;33:99–105.CrossRefGoogle ScholarPubMed
Further reading
Amin, MB, Patel, RM, Oliveira, P, et al. Alveolar soft-part sarcoma of the urinary bladder with urethral recurrence: a unique case with emphasis on differential diagnoses and diagnostic utility of an immunohistochemical panel including TFE3. Am J Surg Pathol 2006;30:1322–5.CrossRefGoogle ScholarPubMed
Bayley, JP, van Minderhout, I, Weiss, MM, et al. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma. BMC Med Genet 2006;7:1.CrossRefGoogle ScholarPubMed
Bolkier, M, Ginesin, Y, Lichtig, C, et al. Lymphangioma of bladder. J Urol 1983;129:1049–50.CrossRefGoogle ScholarPubMed
Cheng, L, Leibovich, B, Cheville, J, et al. Paraganglioma of the urinary bladder: can biologic potential be predicted? Cancer 2000;88:844–52.3.0.CO;2-I>CrossRefGoogle ScholarPubMed
Cheng, L, Nascimento, AG, Neumann, RM, et al. Hemangioma of the urinary bladder. Cancer 1999;86:498–504.3.0.CO;2-6>CrossRefGoogle ScholarPubMed
Cheng, L, Scheithauer, BW, Leibovich, BC, et al. Neurofibroma of the urinary bladder. Cancer 1999;86:505–13.Google ScholarPubMed
Cummings, JM, Wehry, MA, Parra, RO, et al. Schwannoma of the urinary bladder: a case report. Int J Urol 1998;5:496–7.CrossRefGoogle ScholarPubMed
Egawa, S, Uchida, T, Koshiba, K, et al. Malignant fibrous histiocytoma of the bladder with focal rhabdoid tumor differentiation. J Urol 1994;151:154–6.CrossRefGoogle ScholarPubMed
Eltoum, IA, Moore, RJ 3rd, Cook, W, et al. Epithelioid variant of malignant peripheral nerve sheath tumor (malignant schwannoma) of the urinary bladder. Ann Diagn Pathol 1999;3:304–8.CrossRefGoogle ScholarPubMed
Engel, JD, Kuzel, TM, Moceanu, MC, et al. Angiosarcoma of the bladder: a review. Urology 1998;52:778–84.CrossRefGoogle ScholarPubMed
Fletcher, MS, Aker, M, Hill, JT, et al. Granular cell myoblastoma of the bladder. Br J Urol 1985;57:109–10.CrossRefGoogle ScholarPubMed
Grignon, DJ, Ro, JY, Mackay, B, et al. Paraganglioma of the urinary bladder: immunohistochemical, ultrastructural, and DNA flow cytometric studies. Hum Pathol 1991;22:1162–9.CrossRefGoogle ScholarPubMed
Jacobs, MA, Bavendam, T, Leach, GE. Bladder leiomyoma. Urology 1989;34:56–7.CrossRefGoogle ScholarPubMed
Kato, T, Kubota, Y, Saitou, M, et al. Osteosarcoma of the bladder successfully treated with partial cystectomy. J Urol 2000;163:548–9.CrossRefGoogle ScholarPubMed
Lambert, I, Debiec-Rychter, M, Dubin, M, et al. Solid alveolar rhabdomyosarcoma originating from the urinary bladder in an adult. Diagnostic value of molecular genetics. Histopathology 2004;44:508–10.CrossRefGoogle Scholar
Lopez-Beltran, A, Perez-Seoane, C, Montironi, R, et al. Primary primitive neuroectodermal tumour of the urinary bladder: a clinico-pathological study emphasising immunohistochemical, ultrastructural and molecular analyses. J Clin Pathol 2006;59:775–8.CrossRefGoogle ScholarPubMed
Lott, S, Lopez-Beltran, A, MacLennan, GT, et al. Soft tissue tumors of the urinary bladder, part I: myofibroblastic proliferations, benign neoplasms, and tumors of uncertain malignant potential. Hum Pathol 2007;38:807–23.CrossRefGoogle ScholarPubMed
Lott, S, Lopez-Beltran, A, Montironi, R, et al. Soft tissue tumors of the urinary bladder, part II: malignant neoplasms. Hum Pathol 2007;38:963–77.Google ScholarPubMed
Martin, SA, Sears, DL, Sebo, TJ, et al. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic comparison of leiomyoma and leiomyosarcoma. Am J Surg Pathol 2002;26:292–300.CrossRefGoogle ScholarPubMed
Mills, SE, Bova, GS, Wick, MR, et al. Leiomyosarcoma of the urinary bladder. A clinicopathologic and immunohistochemical study of 15 cases. Am J Surg Pathol 1989;13:480–9.CrossRefGoogle ScholarPubMed
Olaya, M, Vicioso, L, Hierro, I, et al. Granular cell tumor of the bladder: a case report. Anal Quant Cytopathol Histpathol 2013;35(5):289–93.Google ScholarPubMed
Pan, C-C, Yu, I-T, Yang, A-H, et al. Clear cell myomelanocytic tumor of the urinary bladder. Am J Surg Pathol 2003;27:689–92.CrossRefGoogle ScholarPubMed
Parfitt, JR, Bella, AJ, Wehrli, BM, et al. Primary PEComa of the bladder treated with primary excision and adjuvant interferon-alpha immunotherapy: a case report. BMC Urol 2006;6:20.CrossRefGoogle ScholarPubMed
Prout, MN, Davis, HL Jr. Hemangiopericytoma of the bladder after polyvinyl alcohol exposure. Cancer 1977;39:1328–30.3.0.CO;2-0>CrossRefGoogle ScholarPubMed
Spina, B, Pacella, E, Introini, C, et al. Primary bladder angiosarcoma with no apparent previous exposure to carcinogens: a case report. Anal Quant Cytopathol Histpathol 2013;35(6):349–52.Google ScholarPubMed
Sung, L, Anderson, JR, Arndt, C, et al. Neurofibromatosis in children with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma study IV. J Pediatr 2004;144:666–8.CrossRefGoogle ScholarPubMed
Westra, WH, Grenko, RT, Epstein, J. Solitary fibrous tumor of the lower urogenital tract: a report of five cases involving the seminal vesicles, urinary bladder, and prostate. Hum Pathol 2000;31:63–8.CrossRefGoogle ScholarPubMed
Further reading
Al-Quran, SZ, Olivares, A, Lin, P, et al. Myeloid sarcoma of the urinary bladder and epididymis as a primary manifestation of acute myeloid leukemia with inv(16). Arch Pathol Lab Med 2006;130:862–6.CrossRefGoogle ScholarPubMed
Hanna, NH, Ulbright, TM, Einhorn, LH. Primary choriocarcinoma of the bladder with the detection of isochromosome 12p. J Urol 2002;167:1781.CrossRefGoogle ScholarPubMed
Hasegeli, UA, Altundag, K, Saglam, A, et al. Granulocytic sarcoma of the urinary bladder. Am J Hematol 2004;75:262–3.Google Scholar
Krober, SM, Aepinus, C, Ruck, P, et al. Extranodal marginal zone B cell lymphoma of MALT type involving the mucosa of both the urinary bladder and stomach. J Clin Pathol 2002;55:554–7.CrossRefGoogle ScholarPubMed
Lemos, N, Melo, CR, Soares, IC, et al. Plasmacytoma of the urethra treated by excisional biopsy. Scand J Urol Nephrol 2000;34:75–6.CrossRefGoogle ScholarPubMed
Mearini, E, Zucchi, A, Costantini, E, et al. Primary Burkitt’s lymphoma of bladder in patient with AIDS. J Urol 2002;167:1397–8.CrossRefGoogle ScholarPubMed
Montironi, R, Santoni, M, Goteri, G, et al. Pseudocarcinomatous hyperplasia secondary to primary lymphoma in the urinary bladder: a case report. Hum Pathol 2015;46(7):1040–4.CrossRefGoogle Scholar
Ohsawa, M, Aozasa, K, Horiuchi, K, et al. Malignant lymphoma of bladder. Report of three cases and review of the literature. Cancer 1993;72:1969–74.3.0.CO;2-A>CrossRefGoogle ScholarPubMed
Taylor, G, Jordan, M, Churchill, B, et al. Yolk sac tumor of the bladder. J Urol 1983;129:591–4.CrossRefGoogle ScholarPubMed
Further reading
Amin, MB, Trpkov, K, Lopez-Beltran, A, et al. Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol 2014;38:e20–34.CrossRefGoogle ScholarPubMed
Baldwin, L, Lee, AHS, Al-Talib, RK, et al. Transitional cell carcinoma of the bladder mimicking lobular carcinoma of the breast: a discohesive variant of urothelial carcinoma. Histopathology 2005;46:50–6.CrossRefGoogle ScholarPubMed
Bates, AW, Baithun, SI. Secondary neoplasms of the bladder are histological mimics of nontransitional cell primary tumours: clinicopathological and histological features of 282 cases. Histopathology 2000;36:32–40.CrossRefGoogle ScholarPubMed
Bolenz, C, Lotan, Y, Ashfaq, R, et al. Estrogen and progesterone hormonal receptor expression in urothelial carcinoma of the bladder. Eur Urol 2009;56:1093–5.CrossRefGoogle ScholarPubMed
Carvalho, JC, Thomas, DG, McHugh, JB, et al. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system. Histopathology 2012;60:597–608.CrossRefGoogle ScholarPubMed
Cimino-Mathews, A, Subhawong, A, Illei, P, et al. GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoi, and metastatic carcinomas. Hum Pathol 2013;44(7):1341–9.CrossRefGoogle ScholarPubMed
Dogra, P, Kumar, A, Singh, A. An unusual case of von Hipple Lindau (VHL) syndrome with bilateral multicentric renal cell carcinoma with synchronous solitary urinary bladder metastasis. Int Urol Nephrol 2007;39:11–14.CrossRefGoogle ScholarPubMed
Epstein, JI, Egevad, L, Humphrey, PA, Montironi, R. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol 2014;38:e6–19.CrossRefGoogle ScholarPubMed
Fisher, MB, Weise, AJ, Powell, IJ. Breast carcinoma metastatic to the bladder and renal pelvis requiring fulguration. Clin Breast Cancer 2005;6:173–4.CrossRefGoogle Scholar
Gatti, G, Zurrida, S, Gilardi, D, et al. Urinary bladder metastases from breast carcinoma: review of the literature starting from a clinical case. Tumori 2005;91:283–6.CrossRefGoogle ScholarPubMed
Gordetsky, J, Epstein, JI. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall. Am J Surg Pathol 2014;38(7):941–5.CrossRefGoogle ScholarPubMed
Kaufmann, O, Baume, H, Dietel, M. Detection of oestrogen receptors in non-invasive and invasive transitional cell carcinomas of the urinary bladder using both conventional immunohistochemistry and the tyramide staining amplification (TSA) technique. J Pathol 1998;186:165–8.3.0.CO;2-Y>CrossRefGoogle ScholarPubMed
Kaufmann, O, Volmerig, J, Dietel, M. Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas. Am J Clin Pathol 2000;113:683–7.CrossRefGoogle ScholarPubMed
Klinger, M. Secondary tumors of the genito-urinary tract. J Urol 1951;65:144–53.CrossRefGoogle ScholarPubMed
Lin, W-C, Chen, J-H. Urinary bladder metastasis from breast cancer with heterogeneic expression of estrogen and progesterone receptors. J Clin Oncol 2007;25:4308–10.CrossRefGoogle ScholarPubMed
Liu, H, Shi, J, Wilkerson, ML, et al. Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas. Am J Clin Pathol 2012;138:57–64.CrossRefGoogle ScholarPubMed
Lotan, TL, Ye, H, Melamed, J, et al. Immunohistochemical panel to identify the primary site of invasive micropapillary carcinoma. Am J Surg Pathol 2009;33:1037–41.CrossRefGoogle ScholarPubMed
Matsuo, M, Koga, S, Nishikido, M, et al. Renal cell carcinoma with solitary metachronous metastasis to the urinary bladder. Urology 2002;60:911–12.CrossRefGoogle Scholar
McAchran, SE, Williams, DH, MacLennan, GT. Renal cell carcinoma metastasis to the bladder. J Urol 2010;184:726–7.CrossRefGoogle ScholarPubMed
Paner, GP, McKenney, JK, Barkan, GA, et al. Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls. Am J Surg Pathol 2011;35:787–98.CrossRefGoogle Scholar
Rao, Q, Williamson, S, Lopez-Beltran, A, et al. Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers. Mod Pathol 2013;26(5):725–32.CrossRefGoogle ScholarPubMed
Shen, SS, Smith, CL, Hsieh, J-T, et al. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue. Cancer 2006;106:2610–16.CrossRefGoogle ScholarPubMed
Silver, SA, Epstein, JI. Adenocarcinoma of the colon simulating primary urinary bladder neoplasia: a report of nine cases. Am J Surg Pathol 1993;17:171–8.CrossRefGoogle ScholarPubMed
Silverstein, LI, Plaine, L, Davis, JE, et al. Breast carcinoma metastatic to bladder. Urology 1987;29:544–7.CrossRefGoogle ScholarPubMed
Sim, SJ, Ro, JY, Ordonez, NG, et al. Metastatic renal cell carcinoma to the bladder: a clinicopathologic and immunohistochemical study. Mod Pathol 1999;12:351–5.Google Scholar
Tamboli, P, Mohsin, SK, Hailemariam, S, et al. Colonic adenocarcinoma metastatic to the urinary tract versus primary tumors of the urinary tract with glandular differentiation: a report of 7 cases and investigation using a limited immunohistochemical panel. Arch Pathol Lab Med 2002;126:1057–63.CrossRefGoogle Scholar
Velcheti, V, Govindan, R. Metastatic cancer involving bladder: a review. Can J Urol 2007;14:3443–8.Google ScholarPubMed
Wang, HL, Lu, DW, Yerian, LM, et al. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Am J Surg Pathol 2001;25:1380–7.CrossRefGoogle ScholarPubMed
Williamson, SR, Zhang, S, Yao, JL, et al. ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin. Mod Pathol 2011;24(8):1120–7.CrossRefGoogle ScholarPubMed
Xiao, GQ, Chow, J, Unger, PD. Metastatic tumors to the urinary bladder: clinicopathologic study of 11 cases. Int J Surg Pathol 2012;20(4):342–8.CrossRefGoogle Scholar
Zhang, M, Wah, C, Epstein, JI. Metastatic renal cell carcinoma to the urinary bladder: a report of 11 cases. Am J Surg Pathol 2014;38(11):1516–21.CrossRefGoogle Scholar